Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(13%)
Results Posted
17%(1 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_1
1
13%
Ph phase_4
1
13%
Ph phase_2
2
25%
Ph not_applicable
2
25%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

not_yet_recruiting113%
active_not_recruiting113%
completed675%

Recent Activity

1 active trials
Showing 5 of 8
completedphase_2

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT04284657
not_yet_recruitingnot_applicable

The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration

NCT06994312
active_not_recruitingphase_2

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

NCT06204432
completedphase_4

Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation

NCT05191290
completedphase_1

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

NCT05067270
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04284657Phase 2

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Completed
NCT06994312Not Applicable

The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration

Not Yet Recruiting
NCT06204432Phase 2

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

Active Not Recruiting
NCT05191290Phase 4

Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation

Completed
NCT05067270Phase 1

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

Completed
NCT01591226Not Applicable

Caffeine and Sodium Citrate Ingestion

Completed
NCT00968565Early Phase 1

Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)

Completed
NCT00004361

Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8